ExpreS²ion Biotechnologies

ExpreS2ion Biotechnologies ApS is a wholly-owned Danish subsidiary of ExpreS2on Biotechnology Holding AB. The subsidiary has developed a unique proprietary platform technology, ExpreS2, for rapid and efficient preclinical and clinical development, as well as robust production of complex proteins for new vaccines and diagnostics. Since its establishment in 2010, the company has collaborated with leading research institutions and companies to produce more than 300 proteins and 40 virus-like particles (VLPs), demonstrating exceptional efficiency and success rates.